BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

405 related articles for article (PubMed ID: 25410968)

  • 41. Formulation and Taste Masking of Ranitidine Orally Disintegrating Tablet.
    Hesari Z; Shafiee A; Hooshfar S; Mobarra N; Mortazavi SA
    Iran J Pharm Res; 2016; 15(4):677-686. PubMed ID: 28243264
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Formulation and Evaluation of Baclofen-Meloxicam Orally Disintegrating Tablets (ODTs) Using Co-Processed Excipients and Improvement of ODTs Performance Using Six Sigma Method.
    Abdelmonem R; Abdellatif MM; Al-Samadi IEI; El-Nabarawi MA
    Drug Des Devel Ther; 2021; 15():4383-4402. PubMed ID: 34690500
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Preparation, characterization, and pharmacokinetics of tilmicosin taste-masked formulation via hot-melt extrusion technology.
    Yan G; Liang Q; Wen X; Peng J; Deng R; Lv L; Ji M; Deng X; Wu L; Feng X; He J
    Colloids Surf B Biointerfaces; 2020 Dec; 196():111293. PubMed ID: 32818925
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Formulation and evaluation of taste-masked levocetirizine dihydrochloride orally disintegrating tablets.
    Devireddy SR; Gonugunta CS; Veerareddy PR
    PDA J Pharm Sci Technol; 2009; 63(6):521-6. PubMed ID: 20169858
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Preparation and evaluation of tablets rapidly disintegrating in saliva containing bitter-taste-masked granules by the compression method.
    Ishikawa T; Watanabe Y; Utoguchi N; Matsumoto M
    Chem Pharm Bull (Tokyo); 1999 Oct; 47(10):1451-4. PubMed ID: 10553641
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Preparation of orally disintegrating tablets with taste-masking function: masking effect in granules prepared with correctives using the dry granulation method and evaluation of tablets prepared using the taste-masked granules.
    Kawano Y; Ito A; Sasatsu M; Machida Y
    Yakugaku Zasshi; 2010 Jan; 130(1):81-6. PubMed ID: 20046070
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Development and evaluation of an oral fast disintegrating anti-allergic film using hot-melt extrusion technology.
    Pimparade MB; Vo A; Maurya AS; Bae J; Morott JT; Feng X; Kim DW; Kulkarni VI; Tiwari R; Vanaja K; Murthy R; Shivakumar HN; Neupane D; Mishra SR; Murthy SN; Repka MA
    Eur J Pharm Biopharm; 2017 Oct; 119():81-90. PubMed ID: 28596037
    [TBL] [Abstract][Full Text] [Related]  

  • 48. 800 mg Darunavir tablets prepared by hot melt extrusion.
    Thommes M; Baert L; Rosier J
    Pharm Dev Technol; 2011; 16(6):645-50. PubMed ID: 20731537
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Development of Oral Flexible Tablet (OFT) Formulation for Pediatric and Geriatric Patients: a Novel Age-Appropriate Formulation Platform.
    Chandrasekaran P; Kandasamy R
    AAPS PharmSciTech; 2017 Aug; 18(6):1972-1986. PubMed ID: 27921260
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Formulation and evaluation of primaquine phosphate taste-masked rapidly disintegrating tablet.
    Shah PP; Mashru RC
    J Pharm Pharmacol; 2008 Oct; 60(10):1279-85. PubMed ID: 18812020
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Orally disintegrating tablet of novel salt of antiepileptic drug: formulation strategy and evaluation.
    Rahman Z; Siddiqui A; Khan MA
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):1300-9. PubMed ID: 23800704
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Microwave-Assisted Development of Orally Disintegrating Tablets by Direct Compression.
    Kande KV; Kotak DJ; Degani MS; Kirsanov D; Legin A; Devarajan PV
    AAPS PharmSciTech; 2017 Aug; 18(6):2055-2066. PubMed ID: 27995465
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Taste-masked and affordable donepezil hydrochloride orally disintegrating tablet as promising solution for non-compliance in Alzheimer's disease patients.
    Liew KB; Tan YT; Peh KK
    Drug Dev Ind Pharm; 2015 Apr; 41(4):583-93. PubMed ID: 24495273
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Hot Melt Extrudates Formulated Using Design Space: One Simple Process for Both Palatability and Dissolution Rate Improvement.
    Malaquias LFB; Schulte HL; Chaker JA; Karan K; Durig T; Marreto RN; Gratieri T; Gelfuso GM; Cunha-Filho M
    J Pharm Sci; 2018 Jan; 107(1):286-296. PubMed ID: 28847477
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Investigating the Use of Polymeric Binders in Twin Screw Melt Granulation Process for Improving Compactibility of Drugs.
    Batra A; Desai D; Serajuddin ATM
    J Pharm Sci; 2017 Jan; 106(1):140-150. PubMed ID: 27578544
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Preparation and evaluation of orally disintegrating tablets containing taste masked microparticles of acetaminophen.
    Ikeuchi-Takahashi Y; Ito S; Itokawa A; Ota M; Onuki Y; Hidaka S; Onishi H
    Pharmazie; 2020 Jan; 75(1):2-6. PubMed ID: 32033625
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Multiparticulate system combining taste masking and immediate release properties for the aversive compound praziquantel.
    Münster M; Schoch C; Schmidt C; Breitkreutz J
    Eur J Pharm Sci; 2017 Nov; 109():446-454. PubMed ID: 28887230
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Formulation and in vitro characterization of novel sildenafil citrate-loaded polyvinyl alcohol-polyethylene glycol graft copolymer-based orally dissolving films.
    Xu LL; Shi LL; Cao QR; Xu WJ; Cao Y; Zhu XY; Cui JH
    Int J Pharm; 2014 Oct; 473(1-2):398-406. PubMed ID: 25079431
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Nebulization performance of biodegradable sildenafil-loaded nanoparticles using the Aeroneb Pro: formulation aspects and nanoparticle stability to nebulization.
    Beck-Broichsitter M; Kleimann P; Gessler T; Seeger W; Kissel T; Schmehl T
    Int J Pharm; 2012 Jan; 422(1-2):398-408. PubMed ID: 22001839
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Fusion production of solid dispersions containing a heat-sensitive active ingredient by hot melt extrusion and Kinetisol dispersing.
    Dinunzio JC; Brough C; Hughey JR; Miller DA; Williams RO; McGinity JW
    Eur J Pharm Biopharm; 2010 Feb; 74(2):340-51. PubMed ID: 19818402
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.